PETMED EXPRESS D/B/A 1-800-PETMEDS ANNOUNCES ITS FIRST QUARTER FINANCIAL RESULTS AND ITS $0.19 PER SHARE QUARTERLY DIVIDENDFirst Quarter Net Income Increased 15%
First Quarter New Order Sales Increased 10%
Pompano Beach, Florida, July 25, 2016 - PetMed Express, Inc. (NASDAQ: PETS) today announced its financial results for the quarter ended June 30, 2016. Net income was $6.6 million, or $0.32 diluted per share, for the quarter ended June 30, 2016, compared to net income of $5.8 million, or $0.29 diluted per share, for the quarter ended June 30, 2015, a 15% increase to net income. Net sales for the quarter ended June 30, 2016 were $72.5 million, compared to $71.6 million for the quarter ended June 30, 2015, an increase of 1.2%. New order sales increased 10%, to $13.3 million for the quarter ended June 30, 2016, compared to $12.1 million for the same quarter in the prior year. The Company's online sales for the quarter ended June 30, 2016 were approximately 82% of all sales compared to 81% for the same quarter the prior year, an increase of 2.9%.
Menderes Akdag, CEO and President, commented: "During the June quarter we saw increases in our new order sales, acquiring approximately 158,000 new customers, compared to 148,000 new customers acquired in the same quarter the prior year. We were further encouraged by our continued advertising efficiency in the quarter, as our new customer acquisition costs were reduced to $37 for the quarter ended June 30, 2016 compared to $53 for the same quarter the prior year. We were able to decrease our operating expenses to improve our bottom line results for the quarter ended June 30, 2016. Our operating expenses decreased by about 274 basis points for the quarter compared to the same quarter last year, which can be attributed to a reduction in advertising spending. For the remainder of Fiscal 2017 we will be preparing to move into our new corporate headquarters and distribution facility, which is expected to occur in our third fiscal quarter."
The Board of Directors declared a quarterly dividend of $0.19 per share on the Company's common stock. The dividend will be payable on August 19, 2016, to shareholders of record at the close of business on August 8, 2016. The Company intends to continue to pay regular quarterly dividends; however, the declaration and payment of future dividends is discretionary and will be subject to a determination by the Board of Directors each quarter following its review of the Company's financial performance.
This morning at 8:30 A.M. Eastern Time, Mr. Akdag will host a conference call to review the quarter's financial results. To access the call, which is open to the public, please dial (888) 455-1758 (toll free) or (203) 827-7025. Callers will be required to supply PETMEDS as the passcode. For those unable to participate in the live event, the call will be available for replay from 10:00 A.M. on July 25, 2016 until August 8, 2016 at 11:59 P.M. To access the replay, call (866) 425-0192 (toll free) or (203) 369-0875, and enter passcode 5500.
Founded in 1996, PetMed Express is America's Largest Pet Pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs and cats at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet through its website at www.1800petmeds.com.
This press release may contain "forward-looking" statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risks and uncertainties, including the Company's ability to meet the objectives included in its business plan. Important factors that could cause results to differ materially from those indicated by such "forward-looking" statements are set forth in Management's Discussion and Analysis of Financial Condition and Results of Operations in the PetMed Express Annual Report on Form 10-K for the year ended March 31, 2016. The Company's future results may also be impacted by other risk factors listed from time to time in its SEC filings, including, but not limited to, the Company's Form 10-Q and its Annual Report on Form 10-K.
For investment relations contact PetMed Express, Inc., Bruce S. Rosenbloom, CFO, 954-979-5995.